Cargando…
Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia
BACKGROUND: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant and age-dependent vascular disorder characterised mainly by mutations in the Endoglin (ENG) or activin receptor-like kinase-1 (ALK1, ACVRL1) genes. METHODS: Here, we have identified 22 ALK1 mutations and 15 ENG mutation...
Autores principales: | Fontalba, Ana, Fernandez-L, Africa, García-Alegria, Eva, Albiñana, Virginia, Garrido-Martin, Eva M, Blanco, Francisco J, Zarrabeitia, Roberto, Perez-Molino, Alfonso, Bernabeu-Herrero, Maria E, Ojeda, Maria-Luisa, Fernandez-Luna, Jose L, Bernabeu, Carmelo, Botella, Luisa M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518546/ https://www.ncbi.nlm.nih.gov/pubmed/18673552 http://dx.doi.org/10.1186/1471-2350-9-75 |
Ejemplares similares
-
Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1
por: Fontalba, Ana, et al.
Publicado: (2013) -
Research on potential biomarkers in hereditary hemorrhagic telangiectasia
por: Botella, Luisa-María, et al.
Publicado: (2015) -
Differential Expression of Circulating Plasma miRNA-370 and miRNA-10a from Patients with Hereditary Hemorrhagic Telangiectasia
por: Ruiz-Llorente, Lidia, et al.
Publicado: (2020) -
Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017) -
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
por: Albiñana, Virginia, et al.
Publicado: (2020)